Valuation: Circio Holding ASA

Market Cap 2.06B 221M 189M 177M 162M 305M 21.08B 310M 2.08B 816M 10.57B 828M 810M 34.96B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 2.06B 221M 189M 177M 162M 305M 21.11B 310M 2.09B 817M 10.59B 829M 811M 35B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+1.65%
1 week-8.37%
Current month+5.49%
1 month+12.05%
3 months-13.84%
6 months+473.61%
Current year+643.13%
1 week 8.34
Extreme 8.34
9.4
1 month 7.89
Extreme 7.89
9.56
Current year 0.98
Extreme 0.978
14.46
1 year 0.57
Extreme 0.569999
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap.
11/30/21 Fiscal year

Chief Executive Officer

120,000 0.1386%
5/19/21 Buy

Director

21,299 0.0246%
12/3/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+1.65%-8.37%+1,371.09%-49.59% 221M
-1.90%+3.12%+81.70%+110.88% 72.21B
+0.87%+15.32%+56.99%+95.59% 63.98B
+1.71%-1.22%+2.71%+501.29% 28.53B
+4.26%+9.06%+62.83%+25.28% 25.07B
+21.96%+21.98%+1.54%+2.50% 28.42B
+2.28%+5.65%+42.00%-12.34% 20.04B
0.00%-2.78%+247.46%+423.83% 18.19B
+3.44%+2.66%+25.17%+534.71% 15.96B
+2.39%+7.96%+44.96%+157.77% 13.48B
Average +3.61%+4.31%+193.65%+178.99% 28.61B
Weighted average by Cap. +2.87%+6.68%+62.55%+165.13%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.16M 5.29M 4.94M 4.53M 8.51M 589M 8.65M 58.23M 22.8M 295M 23.13M 22.63M 977M -45.91M -4.92M -4.22M -3.94M -3.61M -6.8M -470M -6.91M -46.47M -18.2M -236M -18.46M -18.06M -779M
Net Debt -972K -104K -89.31K -83.39K -76.51K -144K -9.95M -146K -984K -385K -4.99M -391K -382K -16.5M 2.24M 240K 206K 193K 177K 332K 22.98M 338K 2.27M 890K 11.53M 903K 883K 38.11M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
26-08-19 NOK 8.650 +1.65% 11,663,619
26-08-18 NOK 8.510 -2.18% 2,227,546
26-08-17 NOK 8.700 -2.25% 2,398,991
26-08-14 NOK 8.900 -2.52% 2,435,422
26-08-13 NOK 9.130 -3.28% 4,917,446

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock